All Outputs (2)

High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction (2023)
Journal Article
Boland, J. W., Boland, E. G., & Currow, D. C. (2023). High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 31(4), Article 211. https://doi.org/10.1007/s00520-023-07669-8

Response to “Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later” (2018)
Journal Article
Boland, J. W., Johnson, M., & Currow, D. (2019). Response to “Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later”. Journal of pain and symptom management, 57(3), e12-e13. https://doi.org/10.1016/j.jpainsymman.2018.11.018